North America Breast Cancer Screening Tests Market Share

Statistics for the 2023 & 2024 North America Breast Cancer Screening Tests market share, created by Mordor Intelligence™ Industry Reports. North America Breast Cancer Screening Tests share report includes a market forecast to 2029 and historical overview. Get a sample of this industry share analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Share of North America Breast Cancer Screening Tests Industry

The North American breast cancer screening tests market is fragmented in nature due to the presence of several companies operating regionally. The competitive landscape includes an analysis of companies, including Agendia BV, Fujifilm Holdings Corporation, Hologic Inc., Metabolomic Technologies Inc., Myriad Genetics, QIAGEN NV, Quest Diagnostics Incorporated, and Siemens Healthineers, among others.

North America Breast Cancer Screening Tests Market Leaders

  1. Allengers Medical Systems Limited

  2. Myriad Genetics

  3. Siemens Healthineers

  4. Hologic Inc.

  5. GENERAL ELECTRIC COMPANY

*Disclaimer: Major Players sorted in no particular order

North America Breast Cancer Screening Tests Market Concentration

North America Breast Cancer Screening Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)